Picture of Eli Lilly and logo

LLY — Eli Lilly and News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Lilly's experimental drug cuts weight by 21% in diabetes trial

Lilly's experimental drug cuts weight by 21% in diabetes trial

- Eli Lilly LLY.N said on Tuesday its experimental drug helped adults with type 2 diabetes and obesity lose an average of nearly 21% of their body weight in a late-stage clinical trial.



(Reporting by Kamal Choudhury in Bengaluru; Editing by Shilpi Majumdar)

((Kamal.Choudhury@thomsonreuters.com;))

Recent news on Eli Lilly and

See all news